Bookmark Article
Palantir has raised its revenue forecast for 2025 following robust quarterly growth, while Pfizer has initiated a second lawsuit against Novo Nordisk and its obesity drug start-up Metsera to impede its $9 billion acquisition bid. Additionally, OpenAI has secured a significant $38 billion computing agreement with Amazon. The Trump administration is also exploring the possibility of promoting broader global adoption of the US dollar.
